ClinicalTrials.gov
public full text
Public Domain
Nitrate Formulations and Exercise Performance
this study compares the acute effects of Nitrate and Nitrate plus citrulline supplementation on physical performance in recreationally trained males and females. This is a cross-over within-participant comparison design concluding three arms (i) 600 mg of Nitrate (N), ii) 600 mg Nitrate and Citrulline (NC) and (iii) Placebo (PL). Conditions N, NC and PL will be tested one week apart, considering a minimum washout period of 72 hours. Dependent variables: * Number of completed repetitions to failure in squat using 75% of 1RM. * Ventilatory thresholds (VT1) and (VT2) and Vo2 max from a progressive to exhaustion running test (PGT) * Lactate post (within 1 min of having completed the PGT) * Rating of perceived exertion (RPE) by the Borg 6-to-20-point scale recorded every 2 min and at the end of the PGT. * Heart rate associated with VT1, VT2, and Vo2max - Heart rate maximum. * Maximal aerobic speed (MAS): calculated from the average speed of the last 2 minutes of the PGT. * time limit test at MAS (conducted after 15 min of having completed the PGT)
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Inorganic NItrate and EXercise Performance in Heart Failure (iNIX-HF): Dose Response#878609
- Effect of Exogenous Ketosis During Ultra-endurance Exercise#848675
- Effects of Home-based or Center-based Aerobic Exercise in Patients With Chronic Kidney Disease#885455
- Effect Of The Presence Of Dynapenia On Posture, Spine Muscle Elasticity, Strength And Endurance In Young Adults#981714
- A Study of Bedaquiline 100 Milligram (mg) Tablets Administered as Different Test Formulations Compared to the Commercial Tablet Formulation (F001) in Healthy Adult Participants#831966
Record · ID 890984
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive